Journal of Clinical Lipidology
Volume 2, Issue 6 , Pages 453-463 , December 2008

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases

  • Eileen E. Ming, MPH, ScD

      Affiliations

    • AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850 USA
    • University of Pennsylvania School of Medicine, Philadelphia, PA USA
    • Corresponding Author InformationCorresponding author
  • ,
  • Michael H. Davidson, MD

      Affiliations

    • University of Chicago Pritzker School of Medicine, Chicago, IL USA
  • ,
  • Sanjay K. Gandhi, PhD

      Affiliations

    • AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850 USA
  • ,
  • Marcelo Marotti, MD, PhD

      Affiliations

    • AstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom
  • ,
  • Carolyn G. Miles, MPH

      Affiliations

    • AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850 USA
  • ,
  • Xiongkan Ke, MS

      Affiliations

    • AstraZeneca Pharmaceuticals LP, 1800 Concord Pike, Wilmington, DE 19850 USA
  • ,
  • James M. McKenney, PharmD

      Affiliations

    • National Clinical Research, Richmond, VA USA

Received 10 October 2008 ,Accepted 19 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1933-2874(08)00893-3

doi: 10.1016/j.jacl.2008.10.007

Journal of Clinical Lipidology
Volume 2, Issue 6 , Pages 453-463 , December 2008